Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Fermenta Biotech will conduct a one-to-one investor meeting on June 26, 2026, in Mumbai. The company plans to discuss its audited financial results for FY26 and the investor presentation. No unpublished price sensitive information will be shared.
Jun 22 2026 17:35:33
Fermenta Biotech Ltd - 506414 - Application To National Stock Exchange Of India Limited For Seeking Approval For Listing And Trading Of The Company'S Equity Shares.
Fermenta Biotech Limited has submitted an application to the National Stock Exchange (NSE) for the listing and trading of its equity shares. This move aims to expand market access and improve liquidity for investors.
Jun 16 2026 19:22:48
Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Fermenta Biotech will hold an in-person investor/analyst meet on June 15, 2026, in Mumbai. The discussions will cover the audited financial results for the year ended March 31, 2026, and the investor presentation, with no unpublished price sensitive information to be shared.
Jun 09 2026 17:08:03
Fermenta Biotech Ltd - 506414 - Corporate Action-Board approves Dividend
Fermenta Biotech board recommended a final dividend of ₹3.75 per share (75% on ₹5 face value) for FY26. Payment by August 21, 2026, pending shareholder approval.
May 26 2026 17:04:49
Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Fermenta Biotech announced its audited FY26 consolidated financial results, with revenue growing 14% YoY to Rs.547.8 crore. The company saw strong operational leverage, with EBITDA (excluding real estate) rising 44% to Rs.120 crore, confirming the FY25 turnaround.
May 26 2026 16:48:47
Read More